{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T07:50:27Z","timestamp":1793260227987,"version":"4.5.0"},"reference-count":55,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,26]],"date-time":"2024-06-26T00:00:00Z","timestamp":1719360000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","ejinme.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Internal Medicine"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.ejim.2024.06.022","type":"journal-article","created":{"date-parts":[[2024,7,4]],"date-time":"2024-07-04T22:13:24Z","timestamp":1720131204000},"page":"63-70","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":55,"special_numbering":"C","title":["Performance of HAS-BLED and DOAC scores to predict major bleeding events in atrial fibrillation patients treated with direct oral anticoagulants: A report from a prospective European observational registry"],"prefix":"10.1016","volume":"128","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-6345-3742","authenticated-orcid":false,"given":"Davide Antonio","family":"Mei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3403-3364","authenticated-orcid":false,"given":"Jacopo Francesco","family":"Imberti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niccol\u00f2","family":"Bonini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3788-8942","authenticated-orcid":false,"given":"Giulio Francesco","family":"Romiti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9460-4435","authenticated-orcid":false,"given":"Bernadette","family":"Corica","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1452-2478","authenticated-orcid":false,"given":"Marco","family":"Proietti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Vitolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7566-1626","authenticated-orcid":false,"given":"Gregory Y.H.","family":"Lip","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9820-4815","authenticated-orcid":false,"given":"Giuseppe","family":"Boriani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.ejim.2024.06.022_bib0001","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1161\/01.STR.22.8.983","article-title":"Atrial fibrillation as an independent risk factor for stroke: the Framingham Study","volume":"22","author":"Wolf","year":"1991","journal-title":"Stroke"},{"issue":"5","key":"10.1016\/j.ejim.2024.06.022_bib0002","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1093\/eurheartj\/ehaa612","volume":"42","author":"Hindricks","year":"2021","journal-title":"Eur Heart J"},{"issue":"1","key":"10.1016\/j.ejim.2024.06.022_bib0003","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1161\/CIR.0000000000001193","article-title":"2023 ACC\/AHA\/ACCP\/HRS guideline for the diagnosis and management of atrial fibrillation: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"149","author":"Joglar","year":"2024","journal-title":"Circulation"},{"key":"10.1016\/j.ejim.2024.06.022_bib0004","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejim.2022.04.023","article-title":"Comparing atrial fibrillation guidelines: focus on stroke prevention, bleeding risk assessment and oral anticoagulant recommendations","volume":"101","author":"Imberti","year":"2022","journal-title":"Eur J Intern Med"},{"issue":"1","key":"10.1016\/j.ejim.2024.06.022_bib0005","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1055\/s-0041-1739411","article-title":"2021 focused update consensus guidelines of the Asia Pacific Heart Rhythm Society on stroke prevention in atrial fibrillation: executive summary","volume":"122","author":"Chao","year":"2022","journal-title":"Thromb Haemost"},{"issue":"11","key":"10.1016\/j.ejim.2024.06.022_bib0006","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.1093\/europace\/euac020","volume":"24","author":"Gorog","year":"2022","journal-title":"Europace"},{"issue":"5","key":"10.1016\/j.ejim.2024.06.022_bib0007","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1378\/chest.10-0134","article-title":"A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the Euro Heart Survey","volume":"138","author":"Pisters","year":"2010","journal-title":"Chest"},{"issue":"46","key":"10.1016\/j.ejim.2024.06.022_bib0008","first-page":"3258","article-title":"The ORBIT bleeding score: a simple bedside score to assess bleeding risk in atrial fibrillation","volume":"36","author":"O'Brien","year":"2015","journal-title":"Eur Heart J"},{"issue":"9","key":"10.1016\/j.ejim.2024.06.022_bib0009","doi-asserted-by":"crossref","DOI":"10.1093\/europace\/euad226","article-title":"Atrial fibrillation and stroke prevention: 25 years of research at EP Europace journal","volume":"25","author":"Lip","year":"2023","journal-title":"Europace"},{"issue":"7","key":"10.1016\/j.ejim.2024.06.022_bib0010","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1093\/ehjqcco\/qcab069","article-title":"Comparison of HAS-BLED and ORBIT bleeding risk scores in atrial fibrillation patients treated with non-vitamin K antagonist oral anticoagulants: a report from the ESC-EHRA EORP-AF general long-term registry","volume":"8","author":"Proietti","year":"2022","journal-title":"Eur Heart J Qual Care Clin Outcomes"},{"issue":"2","key":"10.1016\/j.ejim.2024.06.022_bib0011","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.amjmed.2017.09.009","article-title":"Comparing bleeding risk assessment focused on modifiable risk factors only versus validated bleeding risk scores in atrial fibrillation","volume":"131","author":"Guo","year":"2018","journal-title":"Am J Med"},{"issue":"7","key":"10.1016\/j.ejim.2024.06.022_bib0012","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1007\/s11739-023-03375-9","article-title":"Efficacy and safety of direct oral anticoagulants in older adults with atrial fibrillation: a prospective single-centre cohort study","volume":"18","author":"Catalani","year":"2023","journal-title":"Intern Emerg Med"},{"issue":"3","key":"10.1016\/j.ejim.2024.06.022_bib0013","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.ahj.2005.04.017","article-title":"Clinical classification schemes for predicting hemorrhage: results from the National Registry of Atrial Fibrillation (NRAF)","volume":"151","author":"Gage","year":"2006","journal-title":"Am Heart J"},{"issue":"4","key":"10.1016\/j.ejim.2024.06.022_bib0014","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.jacc.2011.03.031","article-title":"A new risk scheme to predict warfarin-associated hemorrhage: the ATRIA (Anticoagulation and Risk Factors in Atrial Fibrillation) Study","volume":"58","author":"Fang","year":"2011","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"10.1016\/j.ejim.2024.06.022_bib0015","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1093\/europace\/euab303","article-title":"Worldwide trends in oral anticoagulant use in patients with atrial fibrillation from 2010 to 2018: a systematic review and meta-analysis","volume":"24","author":"Grymonprez","year":"2022","journal-title":"Europace"},{"issue":"7","key":"10.1016\/j.ejim.2024.06.022_bib0016","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1093\/europace\/euz032","article-title":"Association between antithrombotic treatment and outcomes at 1-year follow-up in patients with atrial fibrillation: the EORP-AF general long-term registry","volume":"21","author":"Boriani","year":"2019","journal-title":"Europace"},{"key":"10.1016\/j.ejim.2024.06.022_bib0017","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2023.102039","article-title":"Patterns of oral anticoagulant use and outcomes in Asian patients with atrial fibrillation: a post-hoc analysis from the GLORIA-AF registry","volume":"63","author":"Romiti","year":"2023","journal-title":"eClinicalMedicine"},{"key":"10.1016\/j.ejim.2024.06.022_bib0018","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.ejim.2022.10.021","article-title":"Delaying clinical events among patients with non-valvular atrial fibrillation treated with oral anticoagulants: insights from the ARISTOPHANES study","volume":"108","author":"Deitelzweig","year":"2023","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.ejim.2024.06.022_bib0019","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.ejim.2023.10.010","article-title":"Anticoagulation in atrial fibrillation. A large real-world update","volume":"121","author":"Bo","year":"2024","journal-title":"Eur J Intern Med"},{"issue":"5","key":"10.1016\/j.ejim.2024.06.022_bib0020","doi-asserted-by":"crossref","DOI":"10.1093\/europace\/euad120","article-title":"Non-vitamin K antagonist oral anticoagulants in atrial fibrillation patients without previous oral anticoagulants or stable under warfarin: a nationwide cohort study","volume":"25","author":"Liu","year":"2023","journal-title":"Europace"},{"issue":"10","key":"10.1016\/j.ejim.2024.06.022_bib0021","doi-asserted-by":"crossref","DOI":"10.31083\/j.rcm2310334","article-title":"Major hemorrhage risk associated with direct oral anticoagulants in non-valvular atrial fibrillation: a systematic review and meta-analysis","volume":"23","author":"Archontakis-Barakakis","year":"2022","journal-title":"Rev Cardiovasc Med"},{"issue":"12","key":"10.1016\/j.ejim.2024.06.022_bib0022","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1161\/CIRCULATIONAHA.123.064556","article-title":"Development and validation of the DOAC score: a novel bleeding risk prediction tool for patients with atrial fibrillation on direct-acting oral anticoagulants","volume":"148","author":"Aggarwal","year":"2023","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.ejim.2024.06.022_bib0023","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1093\/europace\/eux301","article-title":"Contemporary stroke prevention strategies in 11\u2009096 European patients with atrial fibrillation: a report from the EURObservational Research Programme on Atrial Fibrillation (EORP-AF) Long-Term General Registry","volume":"20","author":"Boriani","year":"2018","journal-title":"Europace"},{"issue":"1","key":"10.1016\/j.ejim.2024.06.022_bib0024","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1111\/j.1538-7836.2009.03678.x","article-title":"Definition of major bleeding in clinical investigations of antihemostatic medicinal products in surgical patients","volume":"8","author":"Schulman","year":"2010","journal-title":"J Thromb Haemost"},{"issue":"3","key":"10.1016\/j.ejim.2024.06.022_bib0025","doi-asserted-by":"crossref","first-page":"837","DOI":"10.2307\/2531595","article-title":"Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach","volume":"44","author":"DeLong","year":"1988","journal-title":"Biometrics"},{"issue":"2","key":"10.1016\/j.ejim.2024.06.022_bib0026","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1002\/sim.2929","article-title":"Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond","volume":"27","author":"Pencina","year":"2008","journal-title":"Stat Med"},{"issue":"6","key":"10.1016\/j.ejim.2024.06.022_bib0027","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1177\/0272989X06295361","article-title":"Decision curve analysis: a novel method for evaluating prediction models","volume":"26","author":"Vickers","year":"2006","journal-title":"Med Decis Mak"},{"issue":"12","key":"10.1016\/j.ejim.2024.06.022_bib0028","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1186\/1471-2105-12-77","article-title":"pROC: an open-source package for R and S+ to analyze and compare ROC curves","volume":"17","author":"Robin","year":"2011","journal-title":"BMC Bioinform."},{"issue":"8","key":"10.1016\/j.ejim.2024.06.022_bib0032","doi-asserted-by":"crossref","DOI":"10.3390\/jcm13082277","article-title":"Comparing the real-world and clinical trial bleeding rates associated with oral anticoagulation treatment for atrial fibrillation","volume":"13","author":"Gue","year":"2024","journal-title":"J Clin Med"},{"issue":"9921","key":"10.1016\/j.ejim.2024.06.022_bib0033","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/S0140-6736(13)62343-0","article-title":"Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials","volume":"383","author":"Ruff","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.ejim.2024.06.022_bib0034","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.ahj.2019.08.012","article-title":"Safety and effectiveness of dabigatran at 2 years: final outcomes from Phase II of the GLORIA-AF registry program","volume":"218","author":"Mazurek","year":"2019","journal-title":"Am Heart J"},{"issue":"9","key":"10.1016\/j.ejim.2024.06.022_bib0035","doi-asserted-by":"crossref","DOI":"10.1093\/europace\/euad280","article-title":"Outcomes of patients with atrial fibrillation on oral anticoagulation with and without heart failure: the ETNA-AF-Europe registry","volume":"25","author":"Schnabel","year":"2023","journal-title":"Europace"},{"issue":"12","key":"10.1016\/j.ejim.2024.06.022_bib0036","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1056\/NEJMoa0905561","article-title":"Dabigatran versus warfarin in patients with atrial fibrillation","volume":"361","author":"Connolly","year":"2009","journal-title":"N Engl J Med"},{"issue":"10","key":"10.1016\/j.ejim.2024.06.022_bib0037","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1056\/NEJMoa1009638","article-title":"Rivaroxaban versus warfarin in nonvalvular atrial fibrillation","volume":"365","author":"Patel","year":"2011","journal-title":"N Engl J Med"},{"issue":"11","key":"10.1016\/j.ejim.2024.06.022_bib0038","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1056\/NEJMoa1107039","article-title":"Apixaban versus warfarin in patients with atrial fibrillation","volume":"365","author":"Granger","year":"2011","journal-title":"N Engl J Med"},{"issue":"22","key":"10.1016\/j.ejim.2024.06.022_bib0039","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1056\/NEJMoa1310907","article-title":"Edoxaban versus warfarin in patients with atrial fibrillation","volume":"369","author":"Giugliano","year":"2013","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.ejim.2024.06.022_bib0040","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1186\/s12916-020-01695-7","article-title":"Comparing stroke prevention therapy of direct oral anticoagulants and vitamin K antagonists in patients with atrial fibrillation: a nationwide retrospective observational study","volume":"18","author":"Paschke","year":"2020","journal-title":"BMC Med"},{"issue":"7","key":"10.1016\/j.ejim.2024.06.022_bib0041","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.3390\/jcm13072009","article-title":"Inappropriate underdosing of direct oral anticoagulants in atrial fibrillation patients: results from the START2-AF Registry","volume":"13","author":"Poli","year":"2024","journal-title":"J Clin Med"},{"issue":"18","key":"10.1016\/j.ejim.2024.06.022_bib0042","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.118.009766","article-title":"Predicting bleeding events in anticoagulated patients with atrial fibrillation: a comparison between the HAS-BLED and GARFIELD-AF bleeding scores","volume":"7","author":"Proietti","year":"2018","journal-title":"J Am Heart Assoc"},{"issue":"7","key":"10.1016\/j.ejim.2024.06.022_bib0043","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1016\/j.amjcard.2017.06.058","article-title":"Bleeding risk scores in atrial fibrillation and venous thromboembolism","volume":"120","author":"Zulkifly","year":"2017","journal-title":"Am J Cardiol"},{"issue":"6","key":"10.1016\/j.ejim.2024.06.022_bib0044","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1161\/STROKEAHA.118.024305","article-title":"Refining stroke and bleeding prediction in atrial fibrillation by adding consecutive biomarkers to clinical risk scores","volume":"50","author":"Rivera-Caravaca","year":"2019","journal-title":"Stroke"},{"issue":"Suppl 2","key":"10.1016\/j.ejim.2024.06.022_bib0045","doi-asserted-by":"crossref","first-page":"e97","DOI":"10.2459\/JCM.0000000000001461","article-title":"The gray areas of oral anticoagulation for prevention of thromboembolic events in atrial fibrillation patients","volume":"24","author":"Curcio","year":"2023","journal-title":"J Cardiovasc Med"},{"issue":"6","key":"10.1016\/j.ejim.2024.06.022_bib0046","doi-asserted-by":"crossref","first-page":"e13751","DOI":"10.1111\/eci.13751","article-title":"4S-AF scheme and ABC pathway guided management improves outcomes in atrial fibrillation patients","volume":"52","author":"Guo","year":"2022","journal-title":"Eur J Clin Invest"},{"issue":"8","key":"10.1016\/j.ejim.2024.06.022_bib0047","doi-asserted-by":"crossref","DOI":"10.1016\/j.cpcardiol.2023.101752","article-title":"Features of clinical complexity in european patients with atrial fibrillation: a report from a european observational prospective AF registry","volume":"48","author":"Proietti","year":"2023","journal-title":"Curr Probl Cardiol"},{"key":"10.1016\/j.ejim.2024.06.022_bib0048","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.ejim.2022.11.004","article-title":"Impact of ABC (Atrial Fibrillation Better Care) pathway adherence in high-risk subgroups with atrial fibrillation: a report from the ESC-EHRA EORP-AF long-term general registry","volume":"107","author":"Ding","year":"2023","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.ejim.2024.06.022_bib0049","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.ejim.2024.01.033","article-title":"A call to action: the need to apply guidelines recommendations with ABC or SOS to improve stroke prevention and cardiovascular outcomes in patients with atrial fibrillation","volume":"122","author":"Boriani","year":"2024","journal-title":"Eur J Intern Med"},{"issue":"1","key":"10.1016\/j.ejim.2024.06.022_bib0050","doi-asserted-by":"crossref","first-page":"2","DOI":"10.31083\/j.rcm2301002","article-title":"Bleeding risk in patients with atrial fibrillation treated with combined anti-platelet and non-vitamin K antagonist oral anticoagulant therapy","volume":"23","author":"Shin","year":"2022","journal-title":"Rev Cardiovasc Med"},{"issue":"10","key":"10.1016\/j.ejim.2024.06.022_bib0051","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1016\/j.amjmed.2020.03.019","article-title":"Regular bleeding risk assessment associated with reduction in bleeding outcomes: the mAFA-II randomized trial","volume":"133","author":"Guo","year":"2020","journal-title":"Am J Med"},{"issue":"4","key":"10.1016\/j.ejim.2024.06.022_bib0052","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1055\/s-0038-1636534","article-title":"Incident risk factors and major bleeding in patients with atrial fibrillation treated with oral anticoagulants: a comparison of baseline, follow-up and delta HAS-BLED scores with an approach focused on modifiable bleeding risk factors","volume":"118","author":"Chao","year":"2018","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.ejim.2024.06.022_bib0053","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2022.101757","article-title":"Adherence to the Atrial Fibrillation Better Care (ABC) pathway and the risk of major outcomes in patients with atrial fibrillation: a post-hoc analysis from the prospective GLORIA-AF Registry","volume":"55","author":"Romiti","year":"2023","journal-title":"eClinicalMedicine"},{"key":"10.1016\/j.ejim.2024.06.022_bib0054","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.ejim.2022.08.004","article-title":"Adherence to the \"Atrial fibrillation Better Care\" (ABC) pathway in patients with atrial fibrillation and cancer: a report from the ESC-EHRA EUR observational research programme in atrial fibrillation (EORP-AF) general long-term registry","volume":"105","author":"Vitolo","year":"2022","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.ejim.2024.06.022_bib0055","article-title":"Clinical outcomes in metabolically healthy and unhealthy obese and overweight patients with atrial fibrillation: findings from the GLORIA-AF registry","author":"Corica","year":"2023","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.ejim.2024.06.022_bib0056","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.ejim.2023.08.020","article-title":"Efficacy and safety of direct oral anticoagulants vs vitamin K antagonists in patients with atrial fibrillation and end-stage renal disease on hemodialysis: A systematic review and meta-analysis","volume":"119","author":"Kyriakoulis","year":"2024","journal-title":"Eur J Intern Med"},{"issue":"12","key":"10.1016\/j.ejim.2024.06.022_bib0057","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1055\/s-0038-1675400","article-title":"Predicting thromboembolic and bleeding event risk in patients with non-valvular atrial fibrillation: a systematic review","volume":"118","author":"Borre","year":"2018","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.ejim.2024.06.022_bib0058","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.ejim.2023.08.001","article-title":"A new strategy for anticoagulation: the factor XI inhibitors","volume":"116","author":"Vedovati","year":"2023","journal-title":"Eur J Intern Med"}],"container-title":["European Journal of Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620524002772?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620524002772?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,15]],"date-time":"2025-03-15T11:08:43Z","timestamp":1742036923000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0953620524002772"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":55,"alternative-id":["S0953620524002772"],"URL":"https:\/\/doi.org\/10.1016\/j.ejim.2024.06.022","relation":{},"ISSN":["0953-6205"],"issn-type":[{"value":"0953-6205","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Performance of HAS-BLED and DOAC scores to predict major bleeding events in atrial fibrillation patients treated with direct oral anticoagulants: A report from a prospective European observational registry","name":"articletitle","label":"Article Title"},{"value":"European Journal of Internal Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejim.2024.06.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier B.V. on behalf of European Federation of Internal Medicine.","name":"copyright","label":"Copyright"}]}}